Semaglutide is gaining traction as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to release more insulin and reducing https://allenonxq093388.blogsvila.com/35856293/understanding-semaglutide-a-comprehensive-guide